In the present study, we successfully introduced F311I, T315I, and F311I/T315I mutations into the intrinsic BCR::ABL1 gene of TCCS (a TKI-sensitive human Ph+ myeloid leukemia cell line) using the CRISPR/Cas9 system. This evidence concerns the gene BCR and myeloid leukemia.